Medicinal Chemistry: From Drug Design to Drug Development
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 29 June 2024 | Viewed by 209
Special Issue Editors
Interests: medicinal chemistry; antiproliferative agents; neuroprotective agents; phosphodiesterase inhibitors; antioxidant compounds; protein kinase inhibitors; antibacterial agents
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; antiproliferative agents; antiviral agents; molecular docking; antioxidant compounds; protein kinase inhibitors; antibacterial agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Medicinal chemistry and pharmaceutical chemistry represent a reference model capable of fueling a virtuous circuit between environment, growth and well-being. They are a multidisciplinary topics focused on design, optimization and development of new chemical compounds useful as drug. Over the last 20 years, drug design and drug development have proven fundamental for the treatment of many diseases, including cancer, cardiovascular, infectious and neurodegenerative diseases, which today represent the main cause of death in the Western world. This special issue therefore is aimed to collect the updates of medicinal and pharmaceutical chemistry that could support the pharmaceutical development of potential drug. In particular, it is focused on rational design of new organic and inorganic drugs, but also on organic synthesis and reactivity, photochemistry, synthesis of new multifunctional polymeric, metallic and nanostructured materials, advanced methodologies and pharmaceutical technology in the chemical and chemical-pharmaceutical fields. The results reported in the issue will further support medicinal chemistry research to exploit the pharmaceutical potential of new chemical entities.
Dr. Chiara Brullo
Dr. Andrea Spallarossa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- biological targets
- drug synthesis
- drug discovery
- pharmaceutical chemistry
- structure-activity relationships
